Assured Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-63,570
| Closed | -$5.6M | – | 549 |
|
|
2019
Q1 | $5.6M | Buy |
63,570
+48,240
| +315% | +$4.25M | 0.06% | 126 |
|
|
2018
Q4 | $1.1M | Buy |
+15,330
| New | +$1.1M | 0.03% | 419 |
|
|
2017
Q1 | – | Sell |
-22,022
| Closed | -$852K | – | 639 |
|
|
2016
Q4 | $852K | Buy |
22,022
+21,017
| +2,091% | +$813K | 0.02% | 304 |
|
|
2016
Q3 | $51K | Sell |
1,005
-4,896
| -83% | -$248K | ﹤0.01% | 536 |
|
|
2016
Q2 | $268K | Buy |
+5,901
| New | +$268K | 0.01% | 443 |
|
|
2016
Q1 | – | Sell |
-1,995
| Closed | -$113K | – | 650 |
|
|
2015
Q4 | $113K | Sell |
1,995
-9,821
| -83% | -$556K | ﹤0.01% | 497 |
|
|
2015
Q3 | $470K | Buy |
+11,816
| New | +$470K | 0.01% | 337 |
|